Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents-Reference-Cited by-同舟云学术

Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents

Published:2010-05 Issue:5 Volume:159 Page:871-875
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Ben-Dor Itsik,Torguson Rebecca,Scheinowitz Mickey,Li Yanlin,Delhaye Cedric,Wakabayashi Kohei,Maluenda Gabriel,Syed Asmir I.,Collins Sara D.,Gonzalez Manuel A.,Gaglia Michael A.,Xue Zhenyi,Kaneshige Kimberly,Satler Lowell F.,Suddath William O.,Kent Kenneth M.,Pichard Augusto D.,Waksman Ron

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events;Bowry;Am J Cardiol,2008

2. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events;Bhatt;N Engl J Med,2006

3. Variability in platelet responsiveness to clopidogrel among 544 individuals;Serebruany;J Am Coll Cardiol,2005

4. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation;Yusuf;N Engl J Med,2001

5. CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial;Steinhubl;JAMA,2002

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prevalence of bleeding after percutaneous coronary interventions: A systematic review and meta-analysis;Indian Heart Journal;2024-01

2. Ticagrelor is related to nuisance bleeding after flow diversion of unruptured intracranial aneurysms;Neurosurgical Review;2023-06-03

3. Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies;Health Technology Assessment;2023-05

4. Prognosis and the Effect of De-Escalation of Antiplatelet Therapy After Nuisance Bleeding in Patients With Myocardial Infarction;Circulation: Cardiovascular Interventions;2022-12

5. The impact of kidney function in patients on antithrombotic therapy: a post hoc subgroup analysis focusing on recurrent bleeding events from the AFIRE trial;BMC Medicine;2022-02-25